LAPPANO, Rosamaria
 Distribuzione geografica
Continente #
EU - Europa 4.712
NA - Nord America 3.456
AS - Asia 1.013
AF - Africa 161
SA - Sud America 32
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 9.390
Nazione #
US - Stati Uniti d'America 3.394
RU - Federazione Russa 2.327
UA - Ucraina 704
IT - Italia 457
SG - Singapore 442
DE - Germania 407
CN - Cina 358
AT - Austria 315
SE - Svezia 193
SN - Senegal 158
FI - Finlandia 115
TR - Turchia 83
CA - Canada 51
NL - Olanda 43
GB - Regno Unito 39
IN - India 36
BE - Belgio 31
FR - Francia 31
KR - Corea 30
BR - Brasile 28
CZ - Repubblica Ceca 27
HK - Hong Kong 24
AU - Australia 8
EU - Europa 8
IE - Irlanda 8
PK - Pakistan 5
AZ - Azerbaigian 4
IQ - Iraq 3
IR - Iran 3
JM - Giamaica 3
KZ - Kazakistan 3
MX - Messico 3
PA - Panama 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BD - Bangladesh 2
BY - Bielorussia 2
EC - Ecuador 2
EE - Estonia 2
HU - Ungheria 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
PE - Perù 2
AM - Armenia 1
BG - Bulgaria 1
CH - Svizzera 1
CR - Costa Rica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
MA - Marocco 1
MS - Montserrat 1
NG - Nigeria 1
PH - Filippine 1
PL - Polonia 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 9.390
Città #
Moscow 2.318
Chandler 636
Jacksonville 383
Singapore 294
Boardman 293
San Mateo 269
Vienna 229
Dearborn 202
Dakar 158
New York 157
Ashburn 120
Helsinki 105
Lawrence 102
Roxbury 99
Rende 98
Shanghai 96
Izmir 77
Des Moines 66
Florence 56
Brooklyn 53
Ann Arbor 47
Ottawa 41
Beijing 37
Wilmington 34
Inglewood 32
Munich 32
Ogden 32
Seattle 32
Brussels 30
Seoul 30
Bremen 27
Brno 26
Hong Kong 19
Catanzaro 17
Cosenza 17
Council Bluffs 17
Los Angeles 17
Cambridge 16
Guangzhou 16
Houston 16
Bari 15
Falkenstein 14
Redmond 14
Redwood City 14
San Francisco 14
Grafing 11
Pune 10
Wuhan 10
Amantea 9
Dublin 8
Falls Church 8
Kilburn 8
Palermo 8
Toronto 8
Edinburgh 7
Espoo 7
Rome 7
Chicago 6
Frankfurt am Main 6
Jiaxing 6
Jinhua 6
Norwalk 6
Quanzhou 6
Amsterdam 5
Carovigno 5
Catania 5
Nanjing 5
Naples 5
Paris 5
Baku 4
Barnsley 4
Berlin 4
Changsha 4
Grimaldi 4
Hebei 4
London 4
Shenzhen 4
São Paulo 4
Vibo Valentia 4
Yiwu 4
Canberra 3
Central 3
Dalian 3
Faisalabad 3
Gevelsberg 3
Hamburg 3
Heze 3
Jinan 3
Kunming 3
Lamézia 3
Lappeenranta 3
Nantes 3
Nocera Terinese 3
Olgiate Olona 3
Phoenix 3
Princeton 3
Riyadh 3
Scalea 3
Sittard 3
Sydney 3
Totale 6.688
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 2.397
Crystallographic snapshots of host–guest interactions in drugs@metal–organic frameworks: towards mimicking molecular recognition processes 147
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 137
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 121
Functional characterization of the partially purified Sac1p-independent adenine nucleotide transport system (ANTS) from yeast endoplasmic reticulum 120
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 118
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 118
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 115
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) 115
Computational Approaches for the Discovery of GPER Targeting Compounds 112
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 107
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 104
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells 101
Carbazole derivatives as potential novel agonist of GPER 100
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 97
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 93
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 93
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 93
A Biocompatible Aspartic-Decorated Metal-Organic Framework with Tubular Motif Degradable under Physiological Conditions 90
Composition, Antifungal and Antiproliferative Activities of the Hydrodistilled Oils from Leaves and Flower Heads of Pterocephalus nestorianus Nab. 88
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 86
The lauric acid-activated signaling prompts apoptosis in cancer cells 85
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 84
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 84
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 83
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 82
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 80
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 80
GPER mediates activation of HIF1α/VEGF signaling by estrogens 78
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 78
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 78
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 77
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 75
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 75
A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein coupled receptor 30 in some brain areas of the hamster 74
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 74
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells 74
Glycerophospholipid synthesis as a novel drug target against cancer 73
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 72
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 70
HYPOXIA PROMOTES TUBULAR INJURY VIA THE ACTIVATION OF THE ESTROGENIC RECEPTOR GPER AND P75(NTR) 69
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 68
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells 68
SLC37A1 Gene expression is up-regulated by epidermal growth factor in breast cancer cells 67
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 67
Ddr1 affects metabolic reprogramming in breast cancer cells by cross-talking to the insulin/igf system 67
Recent Advances in the Rationale Design of GPER Ligands. 65
Epidermal growth factor up-regulates SLC37A1 gene expression in cancer cells. 65
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells 65
A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer 65
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 64
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 63
Different 6-Aryl-Fulvenes exert anti-proliferative effects on Cancer Cells 63
G protein-coupled receptor 30 expression is up-regulated by EGF and TGFalpha in estrogen receptor alpha-positive cancer cells 63
Cross-talk between GPER and growth factor signaling 62
GPCR modulation in breast cancer 62
Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells 61
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes 58
GPER Function in Breast Cancer: An Overview 58
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells. 58
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 57
GPCRs and cancer 56
Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling 56
IGF-I/IGF-IR Transduction System Involves GPER and DDR1 in the Stimulation of Mesothelioma and Lung Cancer Cells 56
The cholesterol metabolite 25-Hydroxycholesterol activates estrogen receptor α-Mediated signaling in cancer cells and in cardiomyocytes 56
Tamoxifen and epidermal growth factor induce the aggregation of MCF7 breast cancer cells up-regulating E-cadherin expression 56
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 55
Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer 55
New titanocene derivatives with high antiproliferative activity against breast cancer cells 54
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 54
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells 54
Effects of Atrazine on Estrogen Receptor α- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts 53
Recent advances on the stimulatory effects of metals in breast cancer 53
RUOLO DEL RECETTORE p75NTR E DEL RECETTORE ESTROGENICO GPER NEL DANNO IPOSSICO TUBULARE 53
Insulin-like growth factor-I regulates GPER expression and function in cancer cells 52
Structure-activity relationships of resveratrol and derivatives in breast cancer cells 52
The Novel Estrogen Receptor GPR30 Mediates the Proliferative Effects Induced by 17beta-Estradiol on GC-1 Mouse Spermatogonial Cell Line 51
Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators RID D-5386-2011 51
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands. 51
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies 51
The novel estrogen receptor GRP30 mediates the proliferatiive effects induced by 17beta-estradiol onGC-1 mouse spermatogonial cell line 48
Organo-Metallic Compounds: Novel Molecules in Cancer Therapy 47
G protein-coupled receptors: novel targets for drug discovery in cancer 46
Synthesis, characterization and cytotoxic activity on breast cancer cells of new half-titanocene derivatives 46
GPER is involved in the regulation of CYP1b1 expression in breast cancer cells and CAFs 45
Novel Mechanisms Involved in the Stimulatory Effects Exerted by Zinc in Breast Cancer Cells 45
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology 45
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 44
The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17β-estradiol on mouse spermatogonial GC-1 cell line 44
Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts. 44
RUOLO DEL NUOVO RECETTORE ESTROGENICO GPER E DELL'ASSE NGF/TRKA/P75NTR NEL DANNO IPOSSICO TUBULARE RENALE 44
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 43
New metallorganic complexes of groups 3 and 4 as anticancer agents: Possible alterative to cis-platin. 43
Regulation of SLC37A1 gene expression by epidermal growth factor in breast cancer cells 41
The Physiopathological Role of the Exchangers Belonging to the SLC37 Family 41
ESTROGENIC GPR30 SIGNALLING INDUCES PROLIFERATION AND MIGRATION OF BREAST CANCER CELLS THROUGH CTGF 40
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action 38
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer 38
New titanocene derivatives: synthesis and cytotoxic activity. 38
Response to "Comment on 'Effects of Atrazine on Estrogen Receptor 〈- and G Protein-Coupled Receptor 30-Mediated Signaling and Proliferation in Cancer Cells and Cancer-Associated Fibroblasts'". 36
Totale 9.238
Categoria #
all - tutte 55.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.891


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020273 0 0 0 0 0 0 0 92 36 20 91 34
2020/2021726 98 5 86 97 14 90 20 121 37 88 5 65
2021/20221.296 6 221 12 85 135 31 14 306 16 16 166 288
2022/20231.703 211 218 76 232 178 139 9 242 172 45 115 66
2023/20242.407 153 69 80 30 55 367 432 426 99 200 162 334
2024/20252.235 554 509 355 318 113 135 119 132 0 0 0 0
Totale 9.613